Sensus Healthcare (SRTS) Price to Sales (2017 - 2025)

Sensus Healthcare has reported Price to Sales for 9 years, with the latest figure at 13.27 in Q4 2025.

• On a quarterly basis, Price to Sales rose 51.86% year-over-year to 13.27 in Q4 2025; TTM through Dec 2025 was 2.38, a 12.67% decrease from a year earlier, with the FY2025 full-year figure at 2.38, down 12.67% from the prior year.
• Price to Sales was 13.27 for Q4 2025 at Sensus Healthcare, up from 7.5 in the prior quarter.
• The five-year high for Price to Sales was 25.02 in Q1 2023, with the low at 3.07 in Q4 2023.
• Average Price to Sales over 5 years is 11.91, with a median of 10.7 recorded in 2024.
• The largest YoY upside for Price to Sales was 184.11% in 2024 against a maximum downside of 76.65% in 2024.
• Over 5 years, Price to Sales stood at 9.21 in 2021, then rose by 0.76% to 9.28 in 2022, then sank by 66.87% to 3.07 in 2023, then soared by 184.11% to 8.74 in 2024, then jumped by 51.86% to 13.27 in 2025.
• The last three Price to Sales figures came in at 13.27 (Q4 2025), 7.5 (Q3 2025), and 10.65 (Q2 2025), per Business Quant data.